Results 331 to 340 of about 14,957,077 (381)

Application of nanobody‑based CAR‑T in tumor immunotherapy (Review). [PDF]

Int J Mol Med
Liu H, Liu X, Zhou X, Duan S, Huang X, Fei H, Kou Y.   +6 more
europepmc   +1 more source

NDST3‐Induced Epigenetic Reprogramming Reverses Neurodegeneration in Parkinson's Disease

Advanced Science, EarlyView.
NDST3‐mediated epigenetic reprogramming revitalizes neuronal circuits in the substantia nigra and striatum to halt dopaminergic neuron degeneration and restore motor function in Parkinson's disease models. This strategy promotes neuronal maintenance and functional recovery, highlighting NDST3's therapeutic potential in neurodegenerative disorders ...
Yujung Chang, Yongwoo Na, Hyeonjoo Im, Garam Yang, Seungseon Yang, Hyun Soo Shim, Chunggoo Kim, GyeungYun Kim, Hyeok Ju Park, Hee Young Kim, Seung Eun Lee, Wonwoong Lee, Yoon Ha, Sungho Park, Jieun Kim, Won‐Young Cho, Woong Sun, Jong‐Seo Kim, Junsang Yoo   +18 more
wiley   +1 more source

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML. [PDF]

Blood Adv
Naik S, Aplenc R, Baumeister SHC, Becilli M, Bhagwat AS, Bonifant CL, Budde LE, Chien CD, Curran KJ, Daniyan AF, Dreyzin A, Gardner RA, Ghorashian S, Gottschalk S, Hill LC, Kohler ME, Lamble A, Locatelli F, Mamonkin M, Omer B, Park JH, Quintarelli C, Rambaldi B, Richards RM, Sallman DA, Sauer T, Shah NN, Subklewe M, Summers C, Tasian SK, Taylor N, Tettamanti S, Verneris MR, Velasquez MP, Gill SI.   +34 more
europepmc   +1 more source

Caffeine-regulated molecular switches for functional control of CAR T cells

Elise Sylvander, Benjamin Salzer, Dominik Emminger, Hayeon Baik, Konstantina Mouratidis, Charlotte U. Zajc, E König, Manfred Lehner, Michael W. Traxlmayr   +8 more
openalex   +1 more source

Dynamics of the Mammalian Placental Metabolome in Placentogenesis and Embryonic Development

Advanced Science, EarlyView.
This study identifies three metabolic stages (E8.5, E9.5–10.5, E11.5–14.5) and two transition periods (E8.5–9.5, E10.5–11.5) in mouse placental development. NAD(H) emerges as a key dynamic metabolite that enhances embryonic growth through accelerated segmentation and increased proliferation of mouse embryonic stem cell (mESC)‐induced presomitic ...
Gang Chen, Zichen Liu, Mengyi Wei, Qian Li, Liang Wu, Kunyuan Yu, Yanhong Xu, Dainan Yu, Wenwu Ma, Hongmei Wang, Ng Shyh‐Chang, Jinglei Zhai   +11 more
wiley   +1 more source

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery. [PDF]

Proc Natl Acad Sci U S A
Wang Y, Ogunnaike E, Yang H, Yuan S, Hong R, Barrett A, Ebong E, Liu B, Dotti G, Hu Q.   +9 more
europepmc   +1 more source

Role of Frailty in Assessing Eligibility for CAR T-Cell Therapy in Haematology. [PDF]

Eur J Haematol
Clesham J, McGrory J, Bannon A, Cox D, Dowling M.   +4 more
europepmc   +1 more source

CAR T-Cell Therapy

Oncology Times, 2017
openaire   +2 more sources

Metabolic reprogramming of CAR T cells: a new frontier in cancer immunotherapy. [PDF]

Front Immunol
Frlic T, Pavlin M.
europepmc   +1 more source

Unleashing CAR-T potential in solid tumors: overcoming intrinsic and extrinsic hurdles to improve therapy. [PDF]

Cancer Immunol Immunother
Zhang Z, Cui D, Wang H, Wu L, Liu X.
europepmc   +1 more source